Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial
- 31 March 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Nephrology
- Vol. 29 (4), 585-592
- https://doi.org/10.1007/s40620-016-0297-2
Abstract
The underlying mechanisms of nephrotic syndrome (NS) are still under debate and the need for more effective and less toxic treatment is challenging. We aimed to evaluate the efficacy of montelukast, a leukotriene receptor antagonist as an add-on therapy, and to explore the leukotriene (LT) biology in steroid-dependent nephrotic syndrome (SDNS). A randomized controlled trial was conducted including 32 patients with SDNS who were randomly assigned to receive standard steroid treatment only [low-dose steroid (LDS) group] or standard steroid therapy plus montelukast (Montelukast group). Urine protein/creatinine ratio, serum albumin, creatinine, cholesterol, and plasma LTs (LTB4/C4/D4/E4) were evaluated in all patients before and after treatment. After treatment, both groups showed a significant decrease of LTB4 and LTC4/D4/E4. Further, the Montelukast group showed a significant decrease in serum creatinine and a significant increase in diastolic blood pressure and protein/creatinine ratio. It also showed a marked decrease in plasma LTC4/D4/E4 compared to the LDS group, although not statistically significant. Our findings highlight the effect of montelukast on renal function, but suggest that the clinical and laboratory efficacy of the addition of montelukast to steroids in maintenance treatment of SDNS is debatable.Keywords
This publication has 25 references indexed in Scilit:
- New Insights into Treatment of Nephrotic Syndrome in ChildrenContributions to nephrology, 2013
- Immune and Inflammatory Role in Renal DiseasePublished by Wiley ,2013
- Interleukin-13, but Not Indomethacin, Increases Cysteinyl-Leukotriene Synthesis in Human Lung MacrophagesJournal of Allergy, 2011
- Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in ratsFundamental & Clinical Pharmacology, 2011
- The podocyte as a direct target of immunosuppressive agentsNephrology Dialysis Transplantation, 2010
- Structures and mechanisms of enzymes in the leukotriene cascadeBiochimie, 2010
- Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and ProteinuriaPediatric Research, 2008
- 5-Lipoxygenase and leukotriene A 4 hydrolase expression in primary nephrotic syndromePediatric Nephrology, 2004
- Acute renal failure and nephrotic syndrome associated with zafirlukast therapyNephrology Dialysis Transplantation, 2003
- Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritisJournal of Lipid Mediators and Cell Signalling, 1995